Kimberley Fillmore
Obstetrics & Gynecology · Lodi, CANPI 1588736508
Payments from drug & device makers
Across 141 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$478
- AbbVie$298
- Lilly USA, LLC$296
- Organon$183
- Pfizer$158
- Hologic Sales And Service, LLC$152
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,695100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 26 | $478 |
| AbbVie | 13 | $298 |
| Lilly USA, LLC | 15 | $296 |
| Organon | 11 | $183 |
| Pfizer | 9 | $158 |
| Hologic Sales And Service, LLC | 7 | $152 |
| Novartis | 6 | $115 |
| Merck | 6 | $99 |
| Boehringer Ingelheim | 4 | $97 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $88 |
| Scilex Pharmaceuticals Inc. | 5 | $81 |
| Exact Sciences | 3 | $73 |
| Abbott | 4 | $62 |
| Biohaven Pharmaceuticals, Inc. | 3 | $58 |
| Indivior Inc. | 2 | $47 |
| Bayer | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Dexcom, Inc. | 1 | $36 |
| Johnson & Johnson | 2 | $35 |
| Alk-abello, Inc | 2 | $30 |
| BD | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $22 |
| Amgen | 1 | $21 |
| Shield Therapeutics Inc | 1 | $20 |
| Phadia US Inc. | 1 | $19 |
| Viiv Healthcare Company | 1 | $19 |
| Edwards Lifesciences | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| GSK | 1 | $13 |
How this compares
$2,695 in reported general payments places this provider in the 80th percentile of 3,784 obstetrics & gynecology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 39 | $57,703 |
| OzempicSemaglutide | 53 | $49,070 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 22 | $5,784 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 11 | $5,245 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,400 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 102 | $2,705 |
| Arnuity ElliptaFluticasone Furoate | 11 | $2,386 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $1,780 |
| Wixela InhubFluticasone Propion/Salmeterol | 13 | $1,617 |
| Quetiapine Fumarate | 27 | $1,551 |
| Gabapentin | 106 | $1,315 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 20 | $1,110 |
| FenofibrateFenofibrate Nanocrystallized | 44 | $991 |
| Ondansetron Hcl | 16 | $823 |
| Levothyroxine Sodium | 66 | $724 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Combivent Respimat | $97 | $62,94850 claims |
| Novo NordiskOzempic | $478 | $49,07053 claims |
| GSKBreo Ellipta, Arnuity Ellipta | $13 | $6,78623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,784 obstetrics & gynecology providers in California.
Other obstetrics & gynecology in Lodi
- Peyman BanooniBeverly Hills$9.2M
- Vellore BhupathyWhittier$4.3M
- Edwin RamirezOxnard$3.5M
- Nam TranSan Francisco$3M
- Dmitriy RomanenkoSouth Gate$2.7M
- Anita NelsonTorrance$2.1M
- Oleg BessLos Angeles$1.7M
- Rovena ReaganSan Diego$1.7M
- Dana Shippdel Mar$1.7M
- Vanessa JacobySan Francisco$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.